Hypoxia-inducible factor-1 modulates upregulation of mutT homolog-1 in colorectal cancer

World Journal of Gastroenterology

Volumn 21, Issue 48, 2015, Pages 13447-13456

  Qiu, Yuan ^a   Zheng, Hong ^a   Sun, Li Hua ^a   Peng, Ke ^a   Xiao, Wei Dong ^a   Yang, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

8 oxo dGTP; Colorectal cancer; Hypoxia; Hypoxia inducible factor 1 ; MutT homolog 1

Indexed keywords

DEOXYGUANOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MUTT HOMOLOG 1 PROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 8-OXODEOXYGUANOSINE TRIPHOSPHATE; 8-OXODGTPASE; DEOXYGUANOSINE PHOSPHATE; DNA LIGASE; HIF1A PROTEIN, HUMAN; PHOSPHATASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CELL GROWTH; CELL HYPOXIA; CLINICAL FEATURE; COLON CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HT 29 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VIVO STUDY; MALE; MIDDLE AGED; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR DIFFERENTIATION; UPREGULATION; CELL PROLIFERATION; COLORECTAL TUMOR; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HT-29 CELL LINE; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR MICROENVIRONMENT; TUMOR VOLUME; XENOGRAFT;

CELL HYPOXIA; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DEOXYGUANINE NUCLEOTIDES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HT29 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; PHOSPHORIC MONOESTER HYDROLASES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR BURDEN; TUMOR MICROENVIRONMENT;

EID: 84953314824     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i48.13447     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420-1425 [PMID: 15467030 DOI: 10.1093/jnci/djh275]
3. Shehade H, Oldenhove G, Moser M. Hypoxia in the intestine or solid tumors: a beneficial or deleterious alarm signal? Eur J Immunol 2014; 44: 2550-2557 [PMID: 25043839 DOI: 10.1002/eji.201444719]
4. Risom L, Lundby C, Thomsen JJ, Mikkelsen L, Loft S, Friis G, Møller P. Acute hypoxia and reoxygenation-induced DNA oxidation in human mononuclear blood cells. Mutat Res 2007; 625: 125-133 [PMID: 17644143 DOI: 10.1016/j.mrfmmm.2007.06.001]
5. Nakabeppu Y, Oka S, Sheng Z, Tsuchimoto D, Sakumi K. Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase. Mutat Res 2010; 703: 51-58 [PMID: 20542142 DOI: 10.1016/j.mrgentox.2010.06.006]
6. Koketsu S, Watanabe T, Nagawa H. Expression of DNA repair protein: MYH, NTH1, and MTH1 in colorectal cancer. Hepatogastroenterology 2004; 51: 638-642 [PMID: 15143881]
7. Kennedy CH, Pass HI, Mitchell JB. Expression of human MutT homologue (hMTH1) protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue. Free Radic Biol Med 2003; 34: 1447-1457 [PMID: 12757855 DOI: 10.1016/S0891-5849(03)00176-X]
8. Wani G, Milo GE, D'Ambrosio SM. Enhanced expression of the 8-oxo-7,8-dihydrodeoxyguanosine triphosphatase gene in human breast tumor cells. Cancer Lett 1998; 125: 123-130 [PMID: 9566706 DOI: 10.1016/S0304-3835(97)00507-7]
9. Iida T, Furuta A, Kawashima M, Nishida J, Nakabeppu Y, Iwaki T. Accumulation of 8-oxo-2'-deoxyguanosine and increased expression of hMTH1 protein in brain tumors. Neuro Oncol 2001; 3: 73-81 [PMID: 11296483]
10. Yoo YG, Christensen J, Gu J, Huang LE. HIF-1α mediates tumor hypoxia to confer a perpetual mesenchymal phenotype for malignant progression. Sci Signal 2011; 4: pt4 [PMID: 21693763 DOI: 10.1126/scisignal.2002072]
11. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625-634 [PMID: 19946328 DOI: 10.1038/onc.2009.441]
12. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 2004; 9 Suppl 5: 10-17 [PMID: 15591418 DOI: 10.1634/theoncologist.9-90005-10]
13. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005; 105: 659-669 [PMID: 15374877 DOI: 10.1182/blood-2004-07-2958]
14. Chan N, Ali M, McCallum GP, Kumareswaran R, Koritzinsky M, Wouters BG, Wells PG, Gallinger S, Bristow RG. Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells. Mol Cancer Res 2014; 12: 1407-1415 [PMID: 25030372 DOI: 10.1158/1541-7786. MCR-14-0246]
15. Filleur S, Courtin A, Ait-Si-Ali S, Guglielmi J, Merle C, Harel-Bellan A, Clézardin P, Cabon F. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res 2003; 63: 3919-3922 [PMID: 12873985]
16. Yoshimura D, Sakumi K, Ohno M, Sakai Y, Furuichi M, Iwai S, Nakabeppu Y. An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress. J Biol Chem 2003; 278: 37965-37973 [PMID: 12857738 DOI: 10.1074/jbc. M306201200]
17. Speina E, Arczewska KD, Gackowski D, Zielińska M, Siomek A, Kowalewski J, Oliński R, Tudek B, Kus̈mierek JT. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients. J Natl Cancer Inst 2005; 97: 384-395 [PMID: 15741575 DOI: 10.1093/jnci/dji058]
18. Gad H, Koolmeister T, Jemth AS, Eshtad S, Jacques SA, Ström CE, Svensson LM, Schultz N, Lundbäck T, Einarsdottir BO, Saleh A, Göktürk C, Baranczewski P, Svensson R, Berntsson RP, Gustafsson R, Strömberg K, Sanjiv K, Jacques-Cordonnier MC, Desroses M, Gustavsson AL, Olofsson R, Johansson F, Homan EJ, Loseva O, Bräutigam L, Johansson L, Höglund A, Hagenkort A, Pham T, Altun M, Gaugaz FZ, Vikingsson S, Evers B, Henriksson M, Vallin KS, Wallner OA, Hammarström LG, Wiita E, Almlöf I, Kalderén C, Axelsson H, Djureinovic T, Puigvert JC, Häggblad M, Jeppsson F, Martens U, Lundin C, Lundgren B, Granelli I, Jensen AJ, Artursson P, Nilsson JA, Stenmark P, Scobie M, Berglund UW, Helleday T. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature 2014; 508: 215-221 [PMID: 24695224 DOI: 10.1038/nature13181]
19. Greijer AE, Delis-van Diemen PM, Fijneman RJ, Giles RH, Voest EE, van Hinsbergh VW, Meijer GA. Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum. Virchows Arch 2008; 452: 535-544 [PMID: 18351386 DOI: 10.1007/s00428-008-0578-9]
20. Xue X, Taylor M, Anderson E, Hao C, Qu A, Greenson JK, Zimmermann EM, Gonzalez FJ, Shah YM. Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res 2012; 72: 2285-2293 [PMID: 22419665 DOI: 10.1158/0008-5472.CAN-11-3836]
21. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5835 [PMID: 10582706]
22. Obtulowicz T, Swoboda M, Speina E, Gackowski D, Rozalski R, Siomek A, Janik J, Janowska B, Ciesla JM, Jawien A, Banaszkiewicz Z, Guz J, Dziaman T, Szpila A, Olinski R, Tudek B. Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients. Mutagenesis 2010; 25: 463-471 [PMID: 20534734 DOI: 10.1093/mutage/geq028]
23. Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, El Sharawy A, Conring M, Koschnick M, Schwiedernoch S, Katalinic A, Kremer B, Fölsch UR, Krawczak M, Fändrich F, Schreiber S, Tepel J, Hampe J. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer 2007; 121: 555-558 [PMID: 17417778 DOI: 10.1002/ijc.22735]
24. Kennedy CH, Cueto R, Belinsky SA, Lechner JF, Pryor WA. Overexpression of hMTH1 mRNA: a molecular marker of oxidative stress in lung cancer cells. FEBS Lett 1998; 429: 17-20 [PMID: 9657375]
25. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-732 [PMID: 13130303 DOI: 10.1038/nrc1187]
26. Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010; 20: 51-56 [PMID: 19942427 DOI: 10.1016/j.gde.2009.10.009]
27. Huber KV, Salah E, Radic B, Gridling M, Elkins JM, Stukalov A, Jemth AS, Göktürk C, Sanjiv K, Strömberg K, Pham T, Berglund UW, Colinge J, Bennett KL, Loizou JI, Helleday T, Knapp S, Superti-Furga G. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature 2014; 508: 222-227 [PMID: 24695225 DOI: 10.1038/nature13194]
28. Dominissini D, He C. Cancer: Damage prevention targeted. Nature 2014; 508: 191-192 [PMID: 24695227 DOI: 10.1038/nature13221]